Viewing data from:

TERCONAZOLE

ANDA

TERCONAZOLE | A077149 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

W.R. GRACE & CO.-CONNTERCONAZOLE

DMF 128871998

QUIMICA SINTETICA SATERCONAZOLE

DMF 146221999

DERIVADOS QUIMICOS SAUTERCONAZOLE

DMF 207352007

TARO PHARMACEUTICAL INDUSTRIES LTDTERCONAZOLE USP (MICRONIZED)

DMF 246632011

JANSSEN PHARMACEUTICA NVInactiveTERCONAZOLE (PRODUCT # R42470)

DMF 59251985

APOTECNIA SAInactiveTERCONAZOLE

DMF 156802001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 5, 2006	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 80MG

0 patents0 exclusivities▴

SUPPOSITORY;VAGINAL | Approved: Mar 17, 2006

No patent or exclusivity listings for this strength.